While the COVID-19 pandemic definitely was the perfect storm, it was also one of the major reasons that pushed the pharma and life sciences field to mature rapidly, almost overnight. Even though the particular subset of the healthcare industry has been a little slow in terms of technology adoption, most players of this field now understand the crucial role technology plays in augmenting their current drug development capabilities, both in terms of speed and accuracy. The potential benefits of technology in healthcare are, therefore, vast, and revolutionary innovations like AI are clearing the way for a cost-effective, efficient and tailored approach to the production of medicinal products.
An important premise of AI is that it can support and analyze vast amounts of data. Critical aspects of the drug development pathway, such as biomarker discovery, outlier identification, and the creation of synthetic control arms, can all benefit from the utilization of AI. This is a far shift from the traditional drug-discovery stage of research, where potential disease targets are identified and testing occurs to understand whether a drug candidate can impact the identified target—a long and complex process that used to take 4-6 years to complete. AI has the potential to compress that timeline and optimize the process, leading to improved or more targeted molecules or compounds for development.
With such innovations boosting accuracy and efficiency, the pharma sector is standing at the cusp of the next digital transformation. In order to assist pharma organizations in shoring up their capabilities with robust solutions and effective services, we have compiled this issue of Pharma Tech Outlook. In this edition, we have listed the top 10 drug discovery solution providers to highlight the ones that can help you escalate your chances of success. Besides, the magazine comprises insights from subject matter experts, CIOs, and CXOs in the pharma sector. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.
We present to you Pharma Tech Outlook’s “Top 10 Drug Discovery Solution Providers in APAC – 2021.”
![Vyant Bio [NASDAQ: VYNT]](/company_logos/w3y4q22272.jpg "Vyant Bio [NASDAQ: VYNT]")
